Aspartame

What Is Aspartame?

Aspartame is a dipeptide methyl ester — it is produced by combining two amino acids, aspartic acid and phenylalanine, in the form of a methyl ester. It is approximately 200 times sweeter than sucrose but provides minimal calories because the dose required for sweetness is so small. Unlike sucralose, aspartame is metabolised — the body cleaves it to phenylalanine, aspartic acid, and methanol upon ingestion. In healthy individuals these metabolites are processed normally; in individuals with phenylketonuria (PKU), the phenylalanine component accumulates to neurotoxic levels.

Aspartame degrades at temperatures above approximately 80°C, making it unsuitable for baking, cooking, or UHT processing — a significant application limitation relative to sucralose and stevia.

Specification & Form

Evidence Note — IARC 2023 Classification

In July 2023, IARC (International Agency for Research on Cancer) classified aspartame as Group 2B: "possibly carcinogenic to humans" based on limited evidence from human observational studies (primarily hepatocellular carcinoma associations). This requires transparent disclosure.

Critical context that must accompany this disclosure:

• Group 2B is IARC's lowest hazard classification — it means "possibly" carcinogenic based on limited evidence, the same category as pickled vegetables, coffee (reclassified in 2016), and mobile phone radiation
• Simultaneously, JECFA completed its own independent safety evaluation and reiterated that aspartame is safe at the current ADI of 40 mg/kg bw/day, finding no sufficient reason to revise this limit
• No major food safety authority (EFSA, FDA, FSSAI) has subsequently suspended or restricted aspartame use in food

Aspartame remains legally approved and commercially used worldwide. Formulators should be aware of this regulatory context and prepared to address consumer questions on it.

Applications

• Cold beverages, soft drinks, squashes
• Chewing gum and confectionery
• Table-top sweeteners and sachets
• Dairy desserts and flavoured milks
• Pharmaceutical sugar-free formulations (syrup, chewable tablets)

*Not suitable for:* baked goods, hot beverages processed at high temperature, UHT dairy products.

Industries Served

Functional Food/Beverage · Confectionery · Pharmaceutical/Nutraceuticals (cold applications)

Buyer Checklist

• Heat stability limitations confirmed against processing requirements — if baking or UHT is involved, use sucralose or stevia instead
• PKU labeling "Contains Phenylalanine" confirmed for all finished products
• IARC 2023 context documented and available for consumer communication
• COA confirming assay/purity
• FSSAI-compliant documentation confirmed
• Pack size and MOQ confirmed directly with team